The relationship of depression in asthma - chronic obstructive pulmonary disease overlap syndrome

被引:10
|
作者
Yeh, Jun-Jun [1 ,2 ,3 ]
Lin, Cheng-Li [4 ,5 ]
Hsu, Wu-Huei [6 ,7 ,8 ]
Kao, Chia-Hung [6 ,7 ,9 ,10 ,11 ]
机构
[1] Ditmanson Med Fdn, Chia Yi Christian Hosp, Chiayi, Taiwan
[2] Chia Nan Univ Pharm & Sci, Tainan, Taiwan
[3] Meiho Univ, Pingtung, Taiwan
[4] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[5] China Med Univ, Coll Med, Taichung, Taiwan
[6] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan
[7] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan
[8] China Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taichung, Taiwan
[9] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan
[10] China Med Univ Hosp, PET Ctr, Taichung, Taiwan
[11] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan
来源
PLOS ONE | 2017年 / 12卷 / 12期
关键词
QUALITY-OF-LIFE; COPD; PREVALENCE; CORTICOSTEROIDS; ANXIETY; IMPACT;
D O I
10.1371/journal.pone.0188017
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose To clarify the relationship between asthma - chronic obstructive pulmonary disease overlap syndrome (ACOS) and depression. Methods We identified 10,911 patients who received an ACOS diagnosis and concurrent treatment between January 2000 and December 2009. Subjects without ACOS were included in the non-ACOS cohort (n = 10,911). Cox proportional hazard regression analysis was performed to compare the risk of depression between the ACOS and non-ACOS cohorts. Results The risk of depression was higher in the ACOS cohort than in the non-ACOS cohort (adjusted hazard ratios (aHRs) = 1.67, 95% confidence interval [CI] = 1.48 - 1.88). In the ACOS cohort, the aHRs for depression were [2.44 (95% CI = 1.45 - 4.11); 2.36 (95% CI = 1.58 - 3.52)] in patients [aged 20 - 39 years; without comorbidity]. In the ACOS cohort, the aHRs for depression were 1.70 (95% CI = 1.51 - 1.93) and 1.84 (95% CI = 1.55 - 2.19) in patients without inhaled corticosteroids (ICSs) and oral steroids (OSs) use, respectively. Moreover, the aHRs for the risk of depression were 1.16 (95% CI = 0.95 - 1.41) and 1.12 (95% CI = 0.96 - 1.29) in patients with ICSs and OSs use, respectively. Conclusion The risk of depression is higher in ACOS patients, even in those without comorbidities or in young adults. The events of the depression were not significant difference in patients receiving the ICSs/OSs between the ACOS and the non-ACOS cohorts.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS)
    Albertson, Timothy E.
    Chenoweth, James A.
    Pearson, Skyler J.
    Murin, Susan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (02) : 213 - 231
  • [42] THE OVERLAP SYNDROME OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ITS PREVALENCE AND CLINICAL CHARACTERISTICS
    Shim, Jae Jung
    Min, Kyung Hoon
    Lee, Eun Joo
    Hur, Gyu Young
    Lee, Seung Heon
    Lee, Sung Yong
    Kim, Je Hyeong
    Lee, Sang Yeub
    Shin, Chol
    In, Kwang Ho
    Kang, Kyung Ho
    [J]. RESPIROLOGY, 2013, 18 : 184 - 184
  • [43] Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome
    Miskoff, Jeffrey A.
    Dewan, Asa
    Chaudhri, Moiuz
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (06)
  • [44] Characterization of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Qualitative Analysis
    Rodrigue, Claudie
    Beauchesne, Marie-France
    Mallette, Valerie
    Lemiere, Catherine
    Larivee, Pierre
    Blais, Lucie
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 14 (03) : 330 - 338
  • [45] Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma
    Rhee, Chin Kook
    Yoon, Hyoung Kyu
    Yoo, Kwang Ha
    Kim, Young Sam
    Lee, Sei Won
    Park, Yong Bum
    Lee, Jin Hwa
    Kim, Yuri
    Kim, Kyungjoo
    Kim, Jinhee
    Oh, Yeon Mok
    Lee, Sang Do
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 11 (02) : 163 - 170
  • [46] Questions in differential diagnosis of bronchial asthma, chronic obstructive pulmonary disease and overlap syndrome
    Tajti, G.
    Papp, Cs.
    Biro, K.
    Pak, K.
    Kepes, Z.
    Erdei, T.
    Gesztelyi, R.
    Szilasi, M.
    Zsuga, J.
    [J]. ACTA PHYSIOLOGICA, 2014, 211 : 105 - 105
  • [47] Reply to: Asthma-chronic obstructive pulmonary disease overlap syndrome: Is prediction feasible?
    Ayub, Irfan Ismail
    Arshad, Abdul Majeed
    Sekar, Prathipa
    Manimaran, Natraj
    Thangaswamy, Dhanasekar
    Chockalingam, Chandrasekar
    [J]. LUNG INDIA, 2018, 35 (06) : 541 - 543
  • [48] Asthma-chronic obstructive pulmonary disease overlap syndrome: A diagnostic puzzle for the clinicians
    Ourania Koltsida
    Antonia Koutsoukou
    Nikolaos G Koulouris
    Nikoletta Rovina
    [J]. World Journal of Respirology, 2016, (02) : 54 - 56
  • [49] Asthma Chronic Obstructive Pulmonary Disease OverlapDefining, Naming, Diagnosing, and Treating Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Sanders, William D.
    [J]. PHYSICIAN ASSISTANT CLINICS, 2023, 8 (04) : 739 - 747
  • [50] Defining Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Godbout, Krystelle
    Gibson, Peter G.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 507 - 519